English | Español

Astellas Pharma Us, Inc.
Carol Ostrow | Dec 3, 2017

Astellas will present AML findings at American Society of Hematology conference
Carrie Bradon | Dec 1, 2017

Astellas study shows women with overactive bladder symptoms use unconventional methods
Carrie Bradon | Nov 25, 2017

Astellas Oncology names C3 Prize winners
Marian Johns | Nov 19, 2017

Astellas receives perfect score on Corporate Equality Index for fourth consecutive year
Marian Johns | Oct 22, 2017

FDA grants fast-track status to Astellas' acute myeloid leukemia drug
Marian Johns | Oct 19, 2017

Astellas Pharma, Seattle Genetics begin clinical trial for bladder cancer treatment
Robert Hadley | Jul 7, 2017

Astellas says gilteritinib may be long-sought treatment in certain acute myeloid leukemia cases
Robert Hadley | Jun 22, 2017

Phase 3 trial of Pfizer’s prostate cancer drug could yield results two years early

Trending
+ Technology/Innovation
Patient Daily | May 8, 2025

Medfluence attends 2025 Annual Clinical Assembly as only strategic marketing firm
+ Technology/Innovation
Patient Daily | May 7, 2025

OTO Forum 2025 highlights innovation in ENT
+ Pharmaceuticals
Patient Daily | May 8, 2025

Pacific Research Institute CEO: Hospitals are leveraging 340B's 'perverse incentives to enrich themselves'
+ Regulatory
Patient Daily | May 12, 2025

Turning Point USA founder: 'Big pharma’s lobbying of Washington DC has long allowed them to price gouge Americans'